Simultaneous quantification of homocysteine and folate in human serum or plasma using liquid chromatography/tandem mass spectrometry

被引:45
作者
Nelson, BC [1 ]
Satterfield, MB [1 ]
Sniegoski, LT [1 ]
Welch, MJ [1 ]
机构
[1] Natl Inst Stand & Technol, Div Analyt Chem, Gaithersburg, MD 20899 USA
关键词
D O I
10.1021/ac050235z
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A unified extraction and quantification procedure based on stable isotope-dilution liquid chromatography/tandem mass spectrometry (LC/MS/MS) has been developed for the simultaneous determination of total homocysteine and folate (5-methyltetrahydrofolic acid and folic acid) levels in human serum and plasma. This is the first report documenting the simultaneous extraction and quantification of these structurally dissimilar analytes. Analytes are quantitatively isolated from samples (500 mu L) prior to LC/MS/MS analysis using a two-step stabilization process combined with C-18 solid-phase extraction. The method exhibits excellent linearity over 4 orders of magnitude for each analyte. Measurement repeatability (RSD, N = 2) ranged from 0.3% to 3% for all analytes over 1 day of analysis. Total method variability (RSD, N = 6) ranged from 0.7% to 10% for all analytes over three independent days of analysis. The accuracy and practical applicability of the method were demonstrated by applying the method to the quantitative determination of each analyte in a new NIST serum Standard Reference Material (NIST SRM 1955 Homocysteine and Folate in Frozen Human Serum) and in a small subset of normal donor plasma samples.
引用
收藏
页码:3586 / 3593
页数:8
相关论文
共 50 条
[1]   Ion suppression in mass spectrometry [J].
Annesley, TM .
CLINICAL CHEMISTRY, 2003, 49 (07) :1041-1044
[2]   Total plasma homocysteine measured by liquid chromatography-tandem mass spectrometry with use of 96-well plates [J].
Arndt, T ;
Guessregen, B ;
Hohl, A ;
Heicke, B .
CLINICAL CHEMISTRY, 2004, 50 (04) :755-757
[3]   The burden of cardiovascular disease: Following the link from hypertension to myocardial infarction and heart failure [J].
Black, HR .
AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (09) :4S-6S
[4]  
Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.3.CO
[5]  
2-S
[6]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[7]  
Budavari S., 1996, MERCK INDEX, V12th
[8]   B-type natriuretic peptide: A review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians [J].
Cardarelli, R ;
Lumicao, TG .
JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE, 2003, 16 (04) :327-333
[9]  
*CDCP, 2004, MMWR-MORBID MORTAL W, V53, P59
[10]  
Chan YM, 1998, CLIN CHEM, V44, pA125